Could Rigorous Diagnosis and Management of Hypertension Reduce Cardiac Events in Patients With Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors?
Аннотация:we agree that for specific subsets of postmenopausal patients, tamoxifen will still represent the adjuvant endocrine therapy of choice.However, while waiting for the promises of personalized medicine to become reality, we shall not agree that "up-front aromatase inhibitors can be recommended only in women who have contraindications to the use of tamoxifen."
